Premium Nahrungsergänzungsmittel | artgerecht

Flupirtine: Effects, Uses and Side Effects

Flupirtine is a centrally acting analgesic used for the treatment of acute pain. It belongs to the class of selective neuronal potassium channel openers (SNEPCO).

Regular tips about health Regular tips about health

Things worth knowing about "Flupirtine"

Flupirtine is a centrally acting analgesic used for the treatment of acute pain. It belongs to the class of selective neuronal potassium channel openers (SNEPCO).

What is Flupirtine?

Flupirtine is a centrally acting analgesic (painkiller) that was used to treat acute pain. It belongs to a unique drug class known as Selective Neuronal Potassium Channel Openers (SNEPCO). Unlike opioids or non-steroidal anti-inflammatory drugs (NSAIDs), flupirtine works through a distinct mechanism involving potassium channels in nerve cells.

In Europe, flupirtine was marketed under the brand name Katadolon. Due to serious safety concerns, particularly regarding liver toxicity, its marketing authorization in the European Union was ultimately withdrawn in 2018.

Mechanism of Action

Flupirtine exerts its analgesic effect through several mechanisms in the central nervous system:

Potassium channel opening: Flupirtine activates voltage-gated potassium channels in nerve cells. This stabilizes the resting membrane potential and reduces neuronal excitability, thereby dampening pain signal transmission.
Indirect NMDA receptor blockade: By stabilizing neuronal membranes, flupirtine indirectly inhibits the activation of NMDA receptors (N-methyl-D-aspartate receptors), which play a key role in the development and chronification of pain.
Muscle-relaxing effect: Flupirtine reduces the excitability of motor neurons, resulting in a centrally mediated muscle relaxant effect without acting directly on muscle tissue.

Indications

Flupirtine was primarily indicated for:

Acute musculoskeletal pain (e.g., back pain, muscle tension)
Postoperative pain
Cancer-related pain (as a reserve analgesic)
Tension-type headaches

Its additional muscle-relaxing properties made it particularly useful in conditions involving painful muscle spasms.

Dosage and Administration

Flupirtine was available in several forms including capsules, suppositories, and injectable solutions. The standard adult dose was 100 mg to 200 mg, taken three to four times daily depending on the severity of pain. The maximum daily dose was 600 mg.

The duration of treatment was strictly limited to a maximum of two weeks due to the significantly increased risk of liver toxicity with prolonged use.

Side Effects

Flupirtine was associated with a range of side effects:

Common: Fatigue, dizziness, nausea, vomiting, dry mouth, gastrointestinal discomfort
Occasional: Sleep disturbances, nervousness, depressive mood, confusion
Rare but serious: Hepatotoxicity (liver damage) up to and including acute liver failure – this was the primary safety concern leading to market withdrawal
Elevated liver enzyme levels (transaminases)

Contraindications

Flupirtine was contraindicated in patients with:

Known liver disease or elevated liver enzymes
Regular alcohol consumption
Concurrent use of other hepatotoxic medications
Myasthenia gravis (a neuromuscular disorder)
Cholestasis (bile flow obstruction)
Pregnancy and breastfeeding

Regulatory Status and Market Withdrawal

The European Medicines Agency (EMA) initiated a risk assessment procedure for flupirtine in 2013 following increasing reports of severe liver damage. This led to a significant restriction of its use, limiting treatment to a maximum of two weeks and requiring regular liver function monitoring. In 2018, the EMA concluded that the benefits of flupirtine no longer outweighed its risks, and the marketing authorization was fully withdrawn across the European Union.

References

European Medicines Agency (EMA): Assessment Report on Flupirtine, 2018. Available at: www.ema.europa.eu
Devulder J. et al. – Flupirtine in pain management: pharmacological properties and clinical use. CNS Drugs. 2010;24(11):867–881.
Friedel H.A., Fitton A. – Flupirtine: a review of its pharmacological properties, and therapeutic efficacy in pain states. Drugs. 1993;45(4):548–569.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.